This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Jul;2(7):489-501.

doi: 10.1038/nrc839.

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Igor Vivanco¹, Charles L Sawyers

Affiliations

Affiliation

¹ Department of Medicine and Molecular Biology Institute, UCLA School of Medicine, 11-935 Factor Building, 10833 LeConte Avenue, Los Angeles, California 90095, USA.

PMID: 12094235
DOI: 10.1038/nrc839

Review

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Igor Vivanco et al. Nat Rev Cancer. 2002 Jul.

. 2002 Jul;2(7):489-501.

doi: 10.1038/nrc839.

Authors

Igor Vivanco¹, Charles L Sawyers

Affiliation

¹ Department of Medicine and Molecular Biology Institute, UCLA School of Medicine, 11-935 Factor Building, 10833 LeConte Avenue, Los Angeles, California 90095, USA.

PMID: 12094235
DOI: 10.1038/nrc839

No abstract available

PubMed Disclaimer

Similar articles

The phosphoinositide 3-kinase pathway.
Cantley LC. Cantley LC. Science. 2002 May 31;296(5573):1655-7. doi: 10.1126/science.296.5573.1655. Science. 2002. PMID: 12040186 Review.
Targeting the PI3K-Akt pathway in human cancer: rationale and promise.
Luo J, Manning BD, Cantley LC. Luo J, et al. Cancer Cell. 2003 Oct;4(4):257-62. doi: 10.1016/s1535-6108(03)00248-4. Cancer Cell. 2003. PMID: 14585353 Review. No abstract available.
Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.
Ott VL, Cambier JC. Ott VL, et al. Semin Immunol. 2002 Feb;14(1):1-6. doi: 10.1006/smim.2001.0336. Semin Immunol. 2002. PMID: 11884225 Review. No abstract available.
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H. Campbell RA, et al. J Biol Chem. 2001 Mar 30;276(13):9817-24. doi: 10.1074/jbc.M010840200. Epub 2001 Jan 3. J Biol Chem. 2001. PMID: 11139588
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.
Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. Franke TF, et al. Cell. 1995 Jun 2;81(5):727-36. doi: 10.1016/0092-8674(95)90534-0. Cell. 1995. PMID: 7774014

See all similar articles

Cited by

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas.
Manca A, Lissia A, Capone M, Ascierto PA, Botti G, Caracò C, Stanganelli I, Colombino M, Sini M, Cossu A, Palmieri G. Manca A, et al. J Transl Med. 2015 Jan 28;13:37. doi: 10.1186/s12967-015-0401-8. J Transl Med. 2015. PMID: 25627962 Free PMC article.
PAK1 mediates resistance to PI3K inhibition in lymphomas.
Walsh K, McKinney MS, Love C, Liu Q, Fan A, Patel A, Smith J, Beaven A, Jima DD, Dave SS. Walsh K, et al. Clin Cancer Res. 2013 Mar 1;19(5):1106-15. doi: 10.1158/1078-0432.CCR-12-1060. Epub 2013 Jan 8. Clin Cancer Res. 2013. PMID: 23300274 Free PMC article.
Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.
Sarfstein R, Friedman Y, Attias-Geva Z, Fishman A, Bruchim I, Werner H. Sarfstein R, et al. PLoS One. 2013 Apr 19;8(4):e61537. doi: 10.1371/journal.pone.0061537. Print 2013. PLoS One. 2013. PMID: 23620761 Free PMC article.
Clinicopathological Significance of Elevated PIK3CA Expression in Gastric Cancer.
Jang SH, Kim KJ, Oh MH, Lee JH, Lee HJ, Cho HD, Han SW, Son MW, Lee MS. Jang SH, et al. J Gastric Cancer. 2016 Jun;16(2):85-92. doi: 10.5230/jgc.2016.16.2.85. Epub 2016 Jun 24. J Gastric Cancer. 2016. PMID: 27433393 Free PMC article.
Signaling pathways and therapeutic interventions in gastric cancer.
Lei ZN, Teng QX, Tian Q, Chen W, Xie Y, Wu K, Zeng Q, Zeng L, Pan Y, Chen ZS, He Y. Lei ZN, et al. Signal Transduct Target Ther. 2022 Oct 8;7(1):358. doi: 10.1038/s41392-022-01190-w. Signal Transduct Target Ther. 2022. PMID: 36209270 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Molecular Biology Databases
- GlyGen glycoinformatics resource
Miscellaneous
- NCI CPTAC Assay Portal